Cargando…

1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Benusiglio, P.R., Korenbaum, C., Ezenfis, J., Geoffron, S., Paul, C., Richard, S., Byrde, V., Guillerm, E., Basset, N., Lotz, J-P., Chabbert-Buffet, N., Gligorov, J., Coulet, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506392/
http://dx.doi.org/10.1016/j.annonc.2020.08.1837
_version_ 1783585007981297664
author Benusiglio, P.R.
Korenbaum, C.
Ezenfis, J.
Geoffron, S.
Paul, C.
Richard, S.
Byrde, V.
Guillerm, E.
Basset, N.
Lotz, J-P.
Chabbert-Buffet, N.
Gligorov, J.
Coulet, F.
author_facet Benusiglio, P.R.
Korenbaum, C.
Ezenfis, J.
Geoffron, S.
Paul, C.
Richard, S.
Byrde, V.
Guillerm, E.
Basset, N.
Lotz, J-P.
Chabbert-Buffet, N.
Gligorov, J.
Coulet, F.
author_sort Benusiglio, P.R.
collection PubMed
description
format Online
Article
Text
id pubmed-7506392
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75063922020-09-23 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic Benusiglio, P.R. Korenbaum, C. Ezenfis, J. Geoffron, S. Paul, C. Richard, S. Byrde, V. Guillerm, E. Basset, N. Lotz, J-P. Chabbert-Buffet, N. Gligorov, J. Coulet, F. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506392/ http://dx.doi.org/10.1016/j.annonc.2020.08.1837 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Benusiglio, P.R.
Korenbaum, C.
Ezenfis, J.
Geoffron, S.
Paul, C.
Richard, S.
Byrde, V.
Guillerm, E.
Basset, N.
Lotz, J-P.
Chabbert-Buffet, N.
Gligorov, J.
Coulet, F.
1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title_full 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title_fullStr 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title_full_unstemmed 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title_short 1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic
title_sort 1773p mainstreamed genetic testing for french breast and ovarian cancer patients and its utility during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506392/
http://dx.doi.org/10.1016/j.annonc.2020.08.1837
work_keys_str_mv AT benusigliopr 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT korenbaumc 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT ezenfisj 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT geoffrons 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT paulc 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT richards 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT byrdev 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT guillerme 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT bassetn 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT lotzjp 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT chabbertbuffetn 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT gligorovj 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic
AT couletf 1773pmainstreamedgenetictestingforfrenchbreastandovariancancerpatientsanditsutilityduringthecovid19pandemic